|
|
Volumn 10, Issue 3, 2001, Pages 235-236
|
|
The 'number needed to treat' with Levetiracetam (LEV): Comparison with the other new antiepileptic drugs (AEDs)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ETIRACETAM;
GABAPENTIN;
LAMOTRIGINE;
OXCARBAZEPINE;
PLACEBO;
TIAGABINE;
TOPIRAMATE;
VIGABATRIN;
ZONISAMIDE;
4 AMINOBUTYRIC ACID;
ACETIC ACID DERIVATIVE;
AMINE;
CARBAMAZEPINE;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
FRUCTOSE;
ISOXAZOLE DERIVATIVE;
NIPECOTIC ACID DERIVATIVE;
PIRACETAM;
TRIAZINE DERIVATIVE;
ASTHENIA;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
EPILEPSY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
SOMNOLENCE;
VERTIGO;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FOCAL EPILEPSY;
ACETIC ACIDS;
ANTICONVULSANTS;
CARBAMAZEPINE;
CLINICAL TRIALS;
COMPARATIVE STUDY;
EPILEPSIES, PARTIAL;
FRUCTOSE;
HUMAN;
ISOXAZOLES;
NIPECOTIC ACIDS;
PIRACETAM;
TRIAZINES;
VIGABATRIN;
AMINES;
CYCLOHEXANECARBOXYLIC ACIDS;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
|
|
EID: 0036014473
PISSN: 10591311
EISSN: None
Source Type: Journal
DOI: 10.1053/seiz.2001.0497 Document Type: Article |
|
Times cited : (5)
|
|
References (8)
|
